
Cyient DLM Q3 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 2
Fundraise
No
Order
N/A
Capex
Yes
1 of 4 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- The company expects healthy growth in revenue supported by a robust and "sufficiently large" pipeline of orders.
- Current order book visibility extends 12 to 18 months, with some orders executable over three years.
- Management is confident about maintaining an order book around INR 2,000 crores for upcoming quarters.
- The business is focused on converting a strong pipeline into orders, with a solid track record of doing so.
- They anticipate growth not only from existing clients by increasing wallet share but also from new client additions.
- Investments in leadership and capacity expansions (e.g., new facilities in Mysore and Bangalore) support growth in medical, industrial, aerospace, and defense sectors.
- SG&A investments have peaked, with expectations to reach and sustain double-digit EBITDA margins as revenue grows.
- Overall, positive outlook for FY25 growth with guidance to be provided in Q4 results.
See what Cyient DLM management said on margin guidance — free account, 30 seconds.
Fundraise plans
No- No explicit mention of any current or future fundraising plans through debt or equity in the transcript.
- The company has repaid external loans using IPO proceeds and currently has gross debt of around INR 250 crores, including internal debt from the parent.
- Management indicated that the IPO proceeds have been mostly utilized as per plans, with no deviations.
- Interest costs are expected to reduce in Q4 as existing loans are repaid.
- The company is actively looking for acquisitions but has not closed any deals yet.
- No specific plans disclosed for raising fresh funds through debt or equity at this time.
See what Cyient DLM management said on order book — free account, 30 seconds.
Capex plans
Yes- A new facility has been identified in Mysore to support growth in the medical and industrial sectors; it is a leased premise in a software park being converted for this purpose, expected ready next financial year.
- The anticipated capex on the Mysore plant is minimal, approximately a couple of million dollars.
- A new precision machining facility was inaugurated in Bangalore, providing 36,000 sq ft of manufacturing capability, focusing on high-value, vertically integrated services.
- Supply chain optimization is underway with a focus on automation, supported by new leadership hires to strengthen capabilities.
- No significant additional SG&A or capital investments are currently expected beyond these plans, as stated by management.
- Discussions indicate ongoing capacity utilization optimization, with Mysore near peak and Hyderabad with lower utilization but expected to support future growth.
Track Cyient DLM — get its next earnings analysis in your feed
How does Cyient DLM rank vs peers in Aerospace & Defense?
Pro featureHow does Cyient DLM rank in Aerospace & Defense?
Compare Cyient DLM against every Aerospace & Defense company (Q3 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Cyient DLM's management said in earlier quarters
Others in Aerospace & Defense this season
- NIBE (Q2 FY27)
20.16% ((7,516.37 . Key results statement takeaways from NIBE Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Techera Engineering India (Q2 FY27)
Revenue from Operations for the half year ended September 30, 2026: ₹2,177.90 lakhs (Standalone and Consolidated) . Key results statement takeaways from Techera
- AXISCADES Technologies (Q2 FY27)
Q2 FY27 revenue: ₹359.1 Cr, +20.1% year on year (YoY), +3.6% quarter on quarter (QoQ) (Page 13) . Key investor presentation takeaways from AXISCADES Technologie
- Bharat Dynamics (Q2 FY27)
Revenue from operations for quarter ended September 30, 2026: ₹1,64,415.89 lakh . Key results statement takeaways from Bharat Dynamics Ltd's Q2 FY27 results sta